ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cyclo Therapeutics Inc

Cyclo Therapeutics Inc (CYTH)

0.80
0.0185
(2.37%)
終了 1月21日 6:00AM
0.80
0.00
(0.00%)
取引時間後: 6:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.80
買値
0.78
売値
0.8249
出来高
16,868
0.769999 日の範囲 0.82
0.55 52 週間の範囲 2.115
時価総額
前日終値
0.7815
始値
0.79
最終取引時間
財務取引量
US$ 13,412
VWAP
0.795106
平均取引量 (3 か月)
39,773
発行済株式数
28,768,055
配当利回り
-
PER
-1.15
1 株当たり利益 (EPS)
-0.7
歳入
1.08M
純利益
-20.06M

Cyclo Therapeutics Inc について

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquapl... Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Gainesville, Florida, USA
設立
-
Cyclo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker CYTH. The last closing price for Cyclo Therapeutics was US$0.78. Over the last year, Cyclo Therapeutics shares have traded in a share price range of US$ 0.55 to US$ 2.115.

Cyclo Therapeutics currently has 28,768,055 shares in issue. The market capitalisation of Cyclo Therapeutics is US$22.48 million. Cyclo Therapeutics has a price to earnings ratio (PE ratio) of -1.15.

CYTH 最新ニュース

Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025

Pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (“NPC1”) to be highlighted in an oral presentation Cyclo Therapeutics, Inc. (Nasdaq:...

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

NEWARK, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the first quarter of fiscal year 2025 ended October 31, 2024. “We...

Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Strategic merger with Rafael Holdings to combine two companies and advance Trappsol® Cyclo™ for NPC1 patients expected to close Q4 2024 Company on track for topline data from the 48-week interim...

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

NEWARK, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the fourth quarter and the full fiscal year ended July 31, 2024...

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the...

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Two posters presented at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024 Pivotal TransportNPC™ study is the most comprehensive ongoing controlled pivotal...

Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm

Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm PR Newswire NEW YORK, Aug. 26, 2024 NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.103214.81056257180.69680.820.62717950.72251797CS
40.16826.5822784810.6320.820.55577590.65619248CS
120.0658.843537414970.7350.820.55397730.66002332CS
26-0.41-33.88429752071.211.340.55581350.87250406CS
52-0.94-54.02298850571.742.1150.55634841.22847131CS
156-3.39-80.90692124114.194.30.55691511.53227457CS
260-3.55-81.60919540234.3517.750.551965786.14344737CS

CYTH - Frequently Asked Questions (FAQ)

What is the current Cyclo Therapeutics share price?
The current share price of Cyclo Therapeutics is US$ 0.80
How many Cyclo Therapeutics shares are in issue?
Cyclo Therapeutics has 28,768,055 shares in issue
What is the market cap of Cyclo Therapeutics?
The market capitalisation of Cyclo Therapeutics is USD 22.48M
What is the 1 year trading range for Cyclo Therapeutics share price?
Cyclo Therapeutics has traded in the range of US$ 0.55 to US$ 2.115 during the past year
What is the PE ratio of Cyclo Therapeutics?
The price to earnings ratio of Cyclo Therapeutics is -1.15
What is the cash to sales ratio of Cyclo Therapeutics?
The cash to sales ratio of Cyclo Therapeutics is 21.39
What is the reporting currency for Cyclo Therapeutics?
Cyclo Therapeutics reports financial results in USD
What is the latest annual turnover for Cyclo Therapeutics?
The latest annual turnover of Cyclo Therapeutics is USD 1.08M
What is the latest annual profit for Cyclo Therapeutics?
The latest annual profit of Cyclo Therapeutics is USD -20.06M
What is the registered address of Cyclo Therapeutics?
The registered address for Cyclo Therapeutics is 6714 NW 16TH STREET, SUITE B, GAINESVILLE, FLORIDA, 32653
What is the Cyclo Therapeutics website address?
The website address for Cyclo Therapeutics is www.cyclotherapeutics.com
Which industry sector does Cyclo Therapeutics operate in?
Cyclo Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

CYTH Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock